{"basic_info": {"ticker": "300871", "exchange": "XSHE", "bloomberg_ticker": "300871 CH Equity", "name": "HVSEN BIOTECHNOLOGY CO LTD-A", "industry": "Pharmaceuticals", "name_chinese_simplified": "回盛生物", "period": "2020", "market_value": 4347345920, "total_income": 777458548, "ccy": "人民币元", "shariah_compliance_summary": "unknown"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 712197388, "business_income_over_total_income": 0.9160583414152648}, {"shariah_compliance": "unknown", "income": 65261158, "business_income_over_total_income": 0.08394165601225083}], "details": [{"business_activity_cn": "兽用化药制剂", "business_activity_en": "Veterinary formulation Kayaku", "income": 628029682, "business_income_over_total_income": 0.8077982853434393, "shariah_compliance": "compliant"}, {"business_activity_cn": "兽用原料药", "business_activity_en": "Veterinary medicine raw materials", "income": 62589136, "business_income_over_total_income": 0.0805047885331116, "shariah_compliance": "compliant"}, {"business_activity_cn": "兽用中药制剂", "business_activity_en": "Veterinary medicine preparation", "income": 21578570, "business_income_over_total_income": 0.027755267538713844, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他", "business_activity_en": "other", "income": 65261158, "business_income_over_total_income": 0.08394165601225083, "shariah_compliance": "unknown"}, {"business_activity_cn": "其他业务", "business_activity_en": "Other business", "income": 0, "business_income_over_total_income": 0.0, "shariah_compliance": "unknown"}, {"business_activity_cn": "合计特别调整", "business_activity_en": "Total special adjustments", "income": 0, "business_income_over_total_income": 0.0, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.02323658719760176, "shariah_compliance": "compliant", "amount_over_market_value": 0.02323658719760176}]}